McDermott Awarded New Saudi Aramco Contract

On January 24, McDermott International, Inc. (MDR) announced that it was awarded a new contract with Saudi Aramco. The company reported that this is a large contract for the engineering, procurement, construction, and installation of 13 jackets in the Zuluf, Marjan, Berri, and Abu Safah oil fields off the coast of Saudi Arabia. McDermott expects […]

Read more...

Fluor Receives New Contract Award From Shell

Fluor Corporation (FLR) announced on January 16 that the company was awarded a new contract with Shell. Under the contract, Fluor is responsible for the engineering, procurement, and fabrication of Shell’s Penguins floating production storage and offloading vessel in the North Sea. The amount of the contract was undisclosed but will be booked as revenue […]

Read more...

Myriad Genetics Receives FDA Approval for Breast Cancer Diagnostic Test

On January 12, Myriad Genetics, Inc. (MYGN) announced that the FDA has approved BRACAnalysis CDx as a companion diagnostic for metastatic breast cancer. Healthcare professionals will be able to use this to identify patients with HER2-negative metastatic breast cancer who have a BRCA mutation and may be candidates for treatment with the PARP inhibitor, Lynparza. […]

Read more...

Kohl’s Reports Successful Holiday Sales Numbers and Increases Guidance

Kohl’s Corporation (KSS) reported on January 8 that November and December sales exceeded the previous year by 6.9%. All lines of business and all regions had improved comparable sales from the previous holiday season. Based on the positive holiday results, the company increased earnings guidance for fiscal 2017 to between $4.10 and $4.20 per diluted […]

Read more...

Extended Stay America Extends Paired Share Repurchase Program

Extended Stay America, Inc. and ESH Hospitality, Inc. (STAY) announced on January 2 that the company’s Board of Directors has extended the paired share repurchase program through December 31, 2018. Repurchases can be made at the discretion of the management through open market purchases, private negotiations, or another arrangement. The company reiterated its commitment to […]

Read more...

December 2017 Scorecard

The December 2017 scorecard for the signals generated from Sonal can be downloaded here. The results are summarized in this table: Scorecard Total Repurchases M&A Guidance Contracts Clinical Trials Correct – Prev Close to Next Close 61% 61% 73% 100% 50% 59% Correct – Prev Close to Next Session Peak 89% 84% 87% 100% 96% […]

Read more...